ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver disease

Li, Yu-Yuan; Cao, Chuang-Yu; Zhou, You-lian; Nie, Yu-Qiang; Cao, Jie; Zhou, Yong-Jian*1
Arab Journal of Gastroenterology2020-9DOI: 10.1016/j.ajg.2020.04.018
5被引12阅读
引用收藏
分享

摘要

Background and study aims: To identify the roles and interaction of farnesoid X receptor (FXR) and peroxisome proliferator activated receptors (PPARs) in Non-alcoholic fatty liver disease (NAFLD) pathogenesis. @@@ Material and Methods: 16 C57/BL male FXR knockout (KO) mice and sex- and age-matched C57/BL wild type mice were received either standard rodent chow or high-fat and sucrose diet (Blank control, NAFLD, FXR KO and FXR KO NAFLD) for 8 weeks. After that, all mice were sacrificed. Liver tissues and blood samples were collected for laboratory and RT-PCR examination. @@@ Results: NAFLD, FXR KO and FXR KO NAFLD mouse models were successful established. Compared with blank control, FXR and PPAR-alpha mRNA expression decreased significantly (P < 0.05), PPAR-beta expression increased slightly (P > 0.05), PPAR-gamma expression increased significantly in NAFLD (P < 0.05). Slight increased PPAR-alpha mRNA expression (P > 0.05) and markedly decreased APAR-beta and PPAR-gamma expression (P < 0.05) were found in FXR KO. Compared with FXR KO group, there was a slight increase in APAR-alpha and PPAR-beta mRNA expression (P > 0.05) and significant increase in PPAR-gamma expression (P < 0.05) in FXR KO NAFLD group. Comparison with NAFLD, PPAR-alpha mRNA expression increased slightly (P > 0.05), APAR-beta and PPAR-gamma expression decreased significantly (P < 0.05) in FXR KO NAFLD. @@@ Conclusion: FXR and PPARs interaction may play important roles in NAFLD pathogenesis.

学科与关键词

关键词
NAFLDfarnesoid X receptorFXRPeroxisome proliferator activated receptorsPPARs
相关
加载中…
  • A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
    Zhou, Shipeng; You, Huimin; Qiu, Shuting; Yu, Dawei; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Biomedicine and Pharmacotherapy, 2022, 154: 113577.被引 16
  • Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro
    Zheng, Yi; Zhao, Jian; Miao, Deyu; Xu, Tingting; Wang, Liziniu; Liu, Changhui; Gao, Yong; Yu, Lili; Shen, Chuangpeng*Biomedicine and Pharmacotherapy, 2023, 164: 114957.被引 1
  • Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR
    Guo, Jingyi; Huang, Shangyi; Yi, Qincheng; Liu, Naihua; Cui, Tianqi; Duan, Siwei; Chen, Jiabing; Li, Jiayu; Li, Jun; Wang, Lei*; Gao, Yong*; Nie, Guangning*ACS OMEGA, 2023, 8(29): 26158-26169.
查看全部 →

发表信息

论文状态
公开发表
期刊
Arab Journal of Gastroenterology
发表日期
2020-09
卷期
第 21 卷, 第 3 期
页码
162-168
DOI
10.1016/j.ajg.2020.04.018
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [NSFC81871905]; Guangzhou Technology Projects [2019-03-01-04-2024-0004]

作者

  • L

    Li, Yu-Yuan (第一作者)

    1

  • C

    Cao, Chuang-Yu

    1

查看全部 6 位作者收起作者
  • Z

    Zhou, You-lian

    1

  • N

    Nie, Yu-Qiang

    1

  • C

    Cao, Jie

    1

  • Z

    Zhou, Yong-Jian (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417